PET plays key role in preventive Alzheimer's study
April 19, 2017 -- With projections that the number of people living with Alzheimer's disease in the U.S. could more than triple by the year 2050, 65 research institutions are collaborating on a clinical trial using PET scans to identify the disease in its earliest stages, as well as guide the use of potential therapeutic agents.
PET links midlife vascular risk factors to more amyloid
April 11, 2017 -- Florbetapir-PET scans show that midlife adults with two or more vascular risk factors are significantly more likely to have greater levels of amyloid deposits in their brains later in life than peers with no such risk factors, according to a study published April 11 in the Journal of the American Medical Association.
IBA Molecular forms Curium as new radiopharmacy player
April 6, 2017 -- Radiopharmacy vendor IBA Molecular has combined with recent acquisition Mallinckrodt Nuclear Medicine to form Curium, a new company with a mission to be a global developer, manufacturer, and supplier of SPECT, PET, and therapeutic radiopharmaceuticals.
Reduced FDG dose levels for PET/MRI show mixed results
April 6, 2017 -- Even though a lower dose of FDG did not significantly affect lesion detection for most adult cancer patients undergoing a whole-body PET/MRI scan, German researchers recommend that clinicians stay with recommended levels to avoid artifacts, according to a study published in the Journal of Nuclear Medicine.
Role of imaging modalities is changing for PE diagnosis
March 31, 2017 -- The use of ventilation/perfusion SPECT scans to rule out pulmonary embolism (PE) is evolving. What used to be the definitive test for PE is shifting into a role that harmonizes with the use of pulmonary CT angiography, according to an article in the American Journal of Roentgenology.
FDG-PET/CT can direct biopsies for pediatric cancer
March 8, 2017 -- FDG-PET/CT can play a valuable role in directing image-guided biopsies of pediatric cancer patients, given its ability to detect and discern between malignant and benign regions, according to a study by a group from Saudi Arabia and Canada published in the March issue of the American Journal of Roentgenology.
Novel PET tracer aids recurrent prostate cancer patients
March 8, 2017 -- A study in the March issue of the Journal of Nuclear Medicine is touting the PET radiotracer fluciclovine F-18 for its ability to guide and monitor targeted treatment for recurrent prostate cancer.
Medicare coverage gets easier for oncologic PET tracers
February 17, 2017 -- In September 2013, Medicare coverage for new oncologic PET radiopharmaceuticals underwent a quiet yet significant change. In a new column, Terri Wilson of Blue Earth Diagnostics explains how the changes are making it easier for providers to receive reimbursement for PET studies with the new radiotracers.
Optical technique sorts malignant from benign in brain surgery
February 11, 2017 -- A new microscopy technique sorts healthy from malignant brain tumors, making surgery safer and more precise, according to the U.S. National Institute of Biomedical Imaging and Bioengineering.
SPECT/CT advances abdominal emergency diagnoses
January 31, 2017 -- SPECT/CT can be a valuable resource for diagnosing gastrointestinal and genitourinary bleeding in the emergency room setting, and it does so in a reasonable amount of additional time, according to a study from Stony Brook University.